• About AOP Orphan
    Slideshow Image

    About AOP Orphan

    Since its establishment 1996, AOP Orphan has focused on finding innovative solutions for Rare Diseases. Today AOP Orphan is a European pioneer in the field of Rare Diseases.

  • Patients & Relatives
    Slideshow Image

    Patients & Relatives

    Patients with rare disease often obtain little support. AOP Orphan saw potential in this need and is pleased to provide these patients with individualized therapies.


Hauptinhalt

A Pioneer in Rare Diseases

AOP Orphan was one of the first companies to enter the sector of Rare Diseases in Europe and continues to be a trailblazer in the field of Orphan Diseases to this day. As a specialist in Orphan Diseases, AOP Orphan researches, develops, produces, and distributes innovative solutions in the following therapeutic areas: hematology and oncology, cardiology and pulmonology, neurology and psychiatry, and metabolic diseases. Today AOP Orphan is active at an international level with an export ratio of about 70% and has become a leading company in its home market.

News

INDIANAPOLIS, IN — CONFLUENCE PHARMACEUTICALS and AOP Orphan Pharmaceuticals AG (“AOP”), announced today they have signed a definitive agreement to co-develop and market...

The pharmaceutical company AOP Orphan, a European pioneer in the field of rare diseases, is expanding its sales area for the special preparation Thromboreductin® to...